India's regulator, Central Drugs Standard Control Organization has approved Bharat Biotech India to conduct human clinical trials for its 'COVAXIN'. Phase I and Phase II trials start in July 2020
Others in the queue:
More here: http://bitly.ws/8V7B
Bharath Biotech in collaboration with the Indian Council of Medical Research's(ICMR) National Institute of Virology(NIV)
Others in the queue:
Zydus Cadilla
Serum Institute of India
Panacea Biotec
More here: http://bitly.ws/8V7B
No comments:
Post a Comment